|
|
|
Insider
Information: |
Hearne Michael S |
Relationship: |
Chief Financial Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,620 |
|
Indirect Shares
|
12,767,435 |
|
|
Direct
Value |
$7,465,690 |
|
|
Indirect Value
|
$36,380,806,033 |
|
|
Total
Shares |
12,770,055 |
|
|
Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
20
|
3
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
10
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
-17.1%
|
-97.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-11-19 |
4 |
S |
$1.92 |
$699,930 |
I/I |
(365,289) |
12,767,435 |
0 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-26 |
4 |
B |
$4.26 |
$710,763 |
I/I |
166,932 |
9,804,204 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-03 |
4 |
B |
$4.90 |
$714,783 |
I/I |
145,764 |
8,479,662 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-08-13 |
4 |
B |
$3.65 |
$800,586 |
I/I |
219,465 |
8,958,452 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-27 |
4 |
B |
$4.47 |
$831,762 |
I/I |
185,928 |
9,990,132 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-12-21 |
4 |
B |
$14.58 |
$905,767 |
I/I |
62,144 |
15,300,926 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-04 |
4 |
B |
$24.92 |
$970,772 |
I/I |
38,950 |
13,140,274 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-05 |
4 |
B |
$25.14 |
$1,020,541 |
I/I |
39,456 |
13,179,730 |
1.99 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-04 |
4 |
B |
$4.94 |
$1,065,636 |
I/I |
215,812 |
8,695,474 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-12-22 |
4 |
B |
$14.58 |
$1,107,587 |
I/I |
74,502 |
15,375,428 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2020-06-02 |
4 |
B |
$4.88 |
$1,237,060 |
I/I |
253,553 |
8,333,898 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-09-28 |
4 |
B |
$13.06 |
$1,305,710 |
I/I |
100,000 |
15,227,900 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-06 |
4 |
B |
$27.56 |
$1,561,237 |
I/I |
56,308 |
13,236,038 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-03-08 |
4 |
B |
$18.10 |
$1,874,583 |
I/I |
100,000 |
13,086,038 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-11-18 |
4 |
S |
$1.88 |
$2,081,879 |
I/I |
(1,094,265) |
13,132,724 |
0 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-12-23 |
4 |
B |
$15.43 |
$2,167,853 |
I/I |
139,138 |
15,514,566 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-11-17 |
4 |
S |
$1.99 |
$2,948,748 |
I/I |
(1,287,577) |
14,226,989 |
0 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-08-28 |
4 |
B |
$14.25 |
$14,999,992 |
I/I |
1,052,631 |
15,127,900 |
1.99 |
% |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-26 |
4 |
B |
$26.00 |
$20,000,006 |
I/I |
769,231 |
14,075,269 |
1.99 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2022-08-22 |
4 |
D |
$6.23 |
$59,857,429 |
I/I |
(9,607,934) |
0 |
0 |
- |
|
145 Records found
|
|
Page 6 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|